Coronavirus Notebook: WHO Accelerator Project Languishes, Novel Treatments Are Explored, Gilead Submits US Remdesivir Filing

Gilead files for US approval of remdesivir and boosts investment in manufacturing capacity, more funding is needed for the global ACT Accelerator initiative, and the US and China are rated among the worst responders to the COVID-19 pandemic. 

Coronavirus_Update
Efforts continue to find treatments and vaccines for COVID-19 • Source: Shutterstock

One of the most high-profile international collaborations on tackling the coronavirus pandemic is the ACT Accelerator, a global initiative by government leaders, health organizations, businesses and philanthropic bodies that aims accelerate the development and production of COVID-19 treatments, vaccines and tests and to make them available on an equitable basis.

Several companies have made commitments to allocate some of the worldwide supplies of coronavirus products to the ACT Accelerator since...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from International

More from Geography